The nasal decongestant oxymetazoline and zinc both inhibit production of pro-inflammatory cytokines in bone marrow-derived mast cells

L. Hueltner, M. Tschaikin, S. Koelsch (Neuherberg/Munich, Darmstadt, Germany)

Source: Annual Congress 2006 - Pathophysiology and treatment of infections in COPD
Session: Pathophysiology and treatment of infections in COPD
Session type: Electronic Poster Discussion
Number: 3391
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Hueltner, M. Tschaikin, S. Koelsch (Neuherberg/Munich, Darmstadt, Germany). The nasal decongestant oxymetazoline and zinc both inhibit production of pro-inflammatory cytokines in bone marrow-derived mast cells. Eur Respir J 2006; 28: Suppl. 50, 3391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells
Source: Eur Respir J 2008; 31: 1313-1321
Year: 2008



Theophylline inhibits mobilization of eosinophil induced by interleukin-5 (IL-5) from femoral bone marrow into the blood
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Mast cell tryptase induce alarmin release and secretion of pro-inflammatory cytokines from bronchial epithelial cells
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018



Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009


Effects of long-acting beta2 agonists on Th1 and Th2 chemokines in monocytes and bronchial epithelial cells
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008


Rapamycin reduces eosinophilopoiesis through suppression of IL-5 production by bone marrow ILC2s
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019




Rolipram inhibits eotaxin-3 releasing in human epithelial cells BEAS-2B stimulated with Th2 cytokines
Source: Eur Respir J 2007; 30: Suppl. 51, 219s
Year: 2007

Influence of montelukast on T cell migration, production of Th2-type cytokines and proinflammatory cytokines
Source: Eur Respir J 2004; 24: Suppl. 48, 129s
Year: 2004

Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Eosinophils stimulate the secretion of neutrophil chemoattractants by bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 227s
Year: 2004

Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004

Pro-inflammatory stimuli affect the production of cytokines and growth factors by human bone marrow-derived mesenchymal stem cells
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Allergen-pulsed bone marrow-derived dendritic cells abolish the influx of allergic inflammatory cells in mouse asthma model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006

IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- but not allergen-induced airway neutrophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002

Histamine-stimulated monocytes release microparticles that upregulate IL-8 synthesis by human alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006

Carbachol – induced proinflammatory cytokine release from immortalised bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006

Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003